| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 03/08/2005 | US6864248 Androgenic steroid compounds and a method of making and using the same |
| 03/08/2005 | CA2480712A1 Chondrocyte therapeutic delivery system |
| 03/03/2005 | WO2005019188A1 Fused pyrimidine derivative and use thereof |
| 03/03/2005 | WO2005018657A2 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY |
| 03/03/2005 | WO2004012767A8 Medicinal agent and method for curing erectile dysfunction |
| 03/03/2005 | US20050050589 Soya cell strains with high isoflavone content |
| 03/03/2005 | US20050049424 6-Hydroxy isoflavones derivatives and medicaments involving same |
| 03/03/2005 | US20050049290 Benzimidazole derivatives and their use as gnrh antagonists |
| 03/03/2005 | US20050049264 Suppressing growth of abnormal cells; gastric, brain, colon, pancreatic, lung, renal, ovarian and prostatic cancer |
| 03/03/2005 | US20050049255 Synergistic combination of vasopressin receptor antagonist and phosphodiesterase inhibitor; dysmenorrhoea |
| 03/03/2005 | US20050049250 7-Aikyl and cycloalkyl-substituted imidazotriazinones |
| 03/03/2005 | US20050049233 Transdermal administering of testosterone |
| 03/03/2005 | US20050049231 Local delivery of aromatase inhibitor using intravaginal device; estrogen dependent proliferative disorders of uterus; minimal side effects, longer term treatment, variable dosage |
| 03/03/2005 | US20050049200 Administering a luteinizing hormone-releasing hormone antagonist (LH-RH) in an amount to suppress endogenous LH while maintaining follicle stimulating hormone (FSH) secretion at a natural level and estrogen development is not affected up to ovulation induction |
| 03/03/2005 | US20050049199 Administration of a comparatively short regimen of luteinizing hormone (LH) starting at the beginning of the stimulatory phase, and followed by follicle stimulating hormone (FSH) administration in a controlled ovarian hyperstimulation (COH) treatment to enhance multiple folliculogenesis |
| 03/03/2005 | US20050048628 Immunological binding molecules inhibiting the syncytial fusion of trophoblast |
| 03/03/2005 | US20050048528 Using immunoglobulins and diagnostic and/or prognostic tool for detection and treatment of cell proliferative disorders; immunodiagnostics; immunotherapy |
| 03/03/2005 | US20050048479 Adenylyl and guanylyl cyclases |
| 03/03/2005 | US20050048104 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 03/03/2005 | CA2536313A1 Fused pyrimidine derivative and use thereof |
| 03/02/2005 | EP1509524A1 Xanthine phosphodiesterase v inhibitor polymorphs |
| 03/02/2005 | EP1509489A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/02/2005 | EP1509249A2 Inclusion complexes of rosiglitazone |
| 03/02/2005 | EP1509228A1 Derivatives of 2-(1-benzyl-1h-pyrazolo (3, 4-b)pyridine-3yl) -5-(4-pyridinyl)-4-pyrimidine amine and the use thereof as guanylate cyclase stimulators |
| 03/02/2005 | EP1509215A1 Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women |
| 03/02/2005 | EP1509213A2 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 03/02/2005 | EP1509188A2 Compounds active at the glucocorticoid receptor ii |
| 03/02/2005 | EP0824530B1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 03/02/2005 | CN1589271A Fused heterocyclic succinimide compounds and analogs thereof as modulators of nuclear hormone receptor function |
| 03/02/2005 | CN1589269A Heteroindanes: a new class of potent cannabimimetic ligands |
| 03/02/2005 | CN1589268A Substituted benzopyrans compounds as selective estrogen receptor-beta agonists |
| 03/02/2005 | CN1589261A Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/02/2005 | CN1589258A Novel beta -phenyl- alpha -oxysubstituted propionic derivatives: process for their preparation and their use in the preparation of pharmaceutically important compounds |
| 03/02/2005 | CN1589151A Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 03/02/2005 | CN1589150A Method for obtaining estrogens from mare's urine |
| 03/02/2005 | CN1589141A Medicament for the treatment of viral skin and tumour diseases |
| 03/02/2005 | CN1586618A Method for preparing pure Chinese medicine sex function regeneration factor capsule |
| 03/02/2005 | CN1586606A Chinese medicine for treating male dificiency of kidney, impotence, premature ejaculation and nocturnal emission |
| 03/02/2005 | CN1586597A Ginseng oral disintegration tablet and its preparing process |
| 03/02/2005 | CN1586589A Ginseng stem and leaf total saponin oral disintegration tablet and its preparing method |
| 03/02/2005 | CN1586585A Shenghong heat clearing capsule |
| 03/02/2005 | CN1586572A Oral liquid for female sterility |
| 03/02/2005 | CN1586568A Essence supplement paste |
| 03/02/2005 | CN1586544A Medicinal wine and its producing method |
| 03/02/2005 | CN1586539A Ainsliaea fragrans capsule and its preparing method |
| 03/02/2005 | CN1586533A Composition for strengthening body resistance and restoring and function, strengthening spleen and kidney, relieving metal stress and promoting blood circulation to remove blood stasis |
| 03/02/2005 | CN1586523A Chinese patented medicine for treating complication caused by non-gonorrhea and gonorrhea |
| 03/02/2005 | CN1586522A Chinese medicine capsule for treating hyperplasia of mammary glands and its producing method |
| 03/02/2005 | CN1586519A Chinese medicine for treating women's chronic pelvic infection |
| 03/02/2005 | CN1586517A Chinese medicine preparation for treating gynecologic inflammation |
| 03/02/2005 | CN1586515A Ainsliaca fragrans dripping pill and its preparing method |
| 03/02/2005 | CN1586511A Medicine for treating woman's menopausal syndrome and its preparing method |
| 03/02/2005 | CN1586498A New use of bactericide H4Ag 206 containing silver and its prepared medicine |
| 03/02/2005 | CN1586497A Clindamycin metronidazole vagina effervescent tablet and its preparing method and use |
| 03/02/2005 | CN1586483A Oral disintegration tablet of silaenafil and its pharmaceutically receptible salt and its preparing method |
| 03/02/2005 | CN1191363C Beta-lactamase/amino-glucosidic passive enzyme interfused gene, its expresed products and composition thereof and use |
| 03/02/2005 | CN1191272C Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (VIP) |
| 03/02/2005 | CN1191236C Substituted 6,6-Hetero-dicycloderivative |
| 03/02/2005 | CN1191071C Product of ginsenoside mono compatibility for improving sextual function |
| 03/02/2005 | CN1191060C Topical compositions for prostaglandin El delivery |
| 03/01/2005 | US6861399 Cleaning compositions containing human serine protease T |
| 02/24/2005 | WO2005016928A1 Imidazopyridine derivatives |
| 02/24/2005 | WO2004087195A3 Therapeutic use of modulators of notch and/or kruppel-like factors |
| 02/24/2005 | WO2003061362A3 Methods and compositions for treating polycystic ovary syndrome |
| 02/24/2005 | WO2003018758A3 Reagents and methods for smooth muscle therapies |
| 02/24/2005 | US20050043544 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 02/24/2005 | US20050043536 Sulfonamides |
| 02/24/2005 | US20050043388 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome |
| 02/24/2005 | US20050043352 human YAK family of serine/threonine protein kinases (hyak); use treating diseases of the hematopoietic systems, including anemias, polycythemia, myelodysplastic syndrome, myelosuppression, cytopenia, male contraceptives; 2-(3-Chloro-phenylamino)-7-methoxy-quinoline-3-carboxylic acid for example |
| 02/24/2005 | US20050043303 prophylaxis of cardiovascular disorders comprising administering to mammals inhibitors of cyclic guanosine monophosphate metabolizing phosphodiesterases such as 2-{2-Ethoxy-5-[4-(2-hydroxy-ethyl)-piperazine-1-sulfonyl]-phenyl}-6-methyl-8-propyl-3H-imidazo[1,5-a][1,3,5]triazin-4-one; antiarrythmic agents |
| 02/24/2005 | US20050043299 Inhibitors of dipeptidyl peptidase iv |
| 02/24/2005 | US20050043285 Formulation |
| 02/24/2005 | US20050043281 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system |
| 02/24/2005 | US20050043222 Pharmaceutical combinations comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application |
| 02/24/2005 | US20050042738 Carbohydrate-associated proteins |
| 02/24/2005 | US20050042731 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders |
| 02/24/2005 | US20050042653 Human transport protein homologs |
| 02/24/2005 | US20050042318 Controlling hormone sensitive diseases; solvent extraction of hops, filtration, desolventizing |
| 02/24/2005 | US20050042299 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| 02/24/2005 | US20050042201 Synergistic mixture of glycoprotein and angiogenesis inhibitor comprising angiostatin, thrombostatin, endostatin, interferon, interferon-inducible factor 10, platelet factor, and/or cyclooxygenase inhibitor; antitumor and anticarcinogenic agents |
| 02/24/2005 | US20050042173 Pharmaceuticals, cosmetics or nutraceuticals with a bioadhesive and plasticizer on a biodegradable support for transdermal or transmucosal application |
| 02/24/2005 | DE19828273B4 Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren Transdermal therapeutic system containing hormones and crystallization inhibitors |
| 02/24/2005 | CA2535416A1 Imidazopyridine derivatives |
| 02/23/2005 | EP1507855A2 Elongase genes and uses thereof |
| 02/23/2005 | EP1507765A2 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 02/23/2005 | EP1507760A1 Cyanoguanidine prodrugs |
| 02/23/2005 | EP1507754A1 Alkoxy aryl beta-2 adrenergic receptor agonists |
| 02/23/2005 | EP1507573A1 Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer |
| 02/23/2005 | EP1507558A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 02/23/2005 | EP1507538A1 Norethindrone sustained release formulations and methods associated therewith |
| 02/23/2005 | EP1507535A1 Pyrimidine-2,4,6-trione metallo-proteinase inhibitors |
| 02/23/2005 | EP1507526A2 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same |
| 02/23/2005 | EP1313489B1 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome |
| 02/23/2005 | EP1274710B1 Novel heteroaryl-diazabicycloalkanes |
| 02/23/2005 | EP1119350B1 Rar antagonists as male anti-fertility agents |
| 02/23/2005 | EP1107962B1 Quinolin-2-one derivatives useful as anticancer agents |
| 02/23/2005 | EP1066304B1 Macrolide lhrh antagonists |
| 02/23/2005 | CN1585771A Polycyclic guanine derivative phosphodiesterase V inhibitors |
| 02/23/2005 | CN1585768A Pyrazole derivatives as psychopharmaceuticals |
| 02/23/2005 | CN1585750A Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |